product
Interview: PerkinElmer’s QSightTM LC/MS/MS
Karima Baudin introduces the PerkinElmer QSight™ LC/MS/MS: The Triple Quadrupole Mass Spectrometer that knows the value of time. Discover an exceptional solution for a wide range of applications...
List view / Grid view
PerkinElmer Inc.
whitepaper
Application note: Rapid identification of illicit drug substances using thermal desorption coupled with a portable toroidal trap GC/MS system
This study describes the injection, separation, and identification of 16 drugs compounds in less than 10 minutes using portable gas chromatograph-toroidal ion trap mass spectrometry (PerkinElmer, Torion® T-9 Portable GC/MS) combined with a coiled-wire-filament (CWF) sampling injector to provide an effective tool for onsite analysis of illicit drugs substances...
content_hub
PerkinElmer
15 June 2017 | By
PerkinElmer is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service…
product
Product Hub: PerkinElmer’s NexION® 2000 ICP-MS
The NexION® 2000 ICP-MS is designed to handle any sample matrix, address any interference, and detect any particle size.
whitepaper
Application note: Testing and validation of various antacids for class 1 and 2A elemental impurities
In this paper, PerkinElmer present data to illustrate the successful validation of the NexION® 2000 ICP Mass Spectrometer for the determination of Class 1 and 2A elemental impurities in antacids according to USP General Chapter ...
article
Mass Spectrometry In-Depth Focus 2017
In this Mass Spectrometry In-Depth Focus: Mass spectrometry in the development of protein biologics; and GC-MS applications in pharmaceuticals analysis...
whitepaper
Application note: ICP-optical emission spectroscopy
The U.S. Pharmocopeia is in the process of revising the analytical protocols for the analysis of metals in pharmaceutical products. A detailed summary of the methodology and the changes is available, so only a brief description will be given here...
article
Application Notes & Whitepapers 2016
13 December 2016 | By European Pharmaceutical Review
With the huge range of processes involved in drug discovery and manufacture, it's no wonder we had to create a separate magazine for this content – and as such we have a wide variety of applications...
news
PerkinElmer launches ChemDraw® cloud platform at 2016 ACS Fall National Meeting & Exposition
2 September 2016 | By PerkinElmer Inc
ChemDraw software moves to the cloud for enhanced collaboration among chemists and biologists...
news
PerkinElmer Signals™ Perspectives launches in collaboration with Attivio
18 February 2016 | By PerkinElmer Inc
New data discovery solution leverages Attivio’s platform to provide insight into complex scientific challenges...
article
Screening: In-Depth Focus 2015
6 January 2016 | By Caroline Richards
In this Screening In-depth Focus: High-content screening accelerates discovery rates in the life sciences; Phenotypic screening using 3D tissue culture and whole animal assays; Screening Roundtable...
article
Informatics In-Depth Focus 2015
In this Informatics In-Depth Focus: Informatics in 2025, Methods for the detection of drug-drug interactions in text & Computational approaches to mutagenicity assessments of impurities: in silico methods...
article
Screening In-Depth Focus 2013
In this Screening In-Depth Focus: New approaches to cell based assays for high content screening and analysis; Reduce, reuse, recycle: how drug repositioning is finding its niche in drug discovery; Workshop Review: Biochemical assays for screening. Screening roundtable...
news
PerkinElmer hosts Revolutionaries for Global Health Summit in Brussels
1 March 2013 | By Edelman (On behalf of PerkinElmer)
Revolutionaries for Global Health Summit, 5 -6 March 2013, Brussels...
article
Practical Workshop – Biochemical Assays for Screening
21 February 2013 | By Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany
Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify…
